Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominique Maraninchi

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Cancer Research|December 3, 2004
Gene expression profiling for molecular characterization of inflammatory breast cancer and prediction of response to chemotherapyFrançois Bertucci, Pascal Finetti, Jacques Rougemont, et al.
Experimental Hematology|October 11, 2003
Bone marrow as stem cell source for allogeneic HLA-identical sibling transplantation following reduced-intensity preparative regimenCatherine Faucher, Mohamad Mohty, Norbert Vey, et al.
Experimental Hematology|February 2, 2002
Transient detection of beta-galactosidase activity in hematopoietic cells, following reinjection of retrovirally marked autologous blood progenitors in patients with breast or ovarian cancer receiving high-dose chemotherapyClaude Bagnis, Christian Chabannon, Gwenaelle Gravis, et al.
Blood|April 27, 2011
Individual patient data meta-analysis of randomized trials evaluating IL-2 monotherapy as remission maintenance therapy in acute myeloid leukemiaMarc Buyse, Pierre Squifflet, Beverly J Lange, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 25, 2005
Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study groupMichel Marty, Francesco Cognetti, Dominique Maraninchi, et al.
European Journal of Cancer (Oxford, England : 1990)|December 25, 2004
High-dose chemotherapy with haematopoietic stem cell transplantation for metastatic breast cancer patients: final results of the French multicentric randomised CMA/PEGASE 04 protocolJean-Pierre Lotz, Hervé Curé, Maud Janvier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 28, 2005
Early allogeneic stem-cell transplantation for young adults with acute myeloblastic leukemia in first complete remission: an intent-to-treat long-term analysis of the BGMT experienceEric Jourdan, Jean-Michel Boiron, Nicole Dastugue, et al.
Blood|August 30, 2003
Reduced-intensity preparative regimen and allogeneic stem cell transplantation for advanced solid tumorsDidier Blaise, Jacques Olivier Bay, Catherine Faucher, et al.
Oncogene|November 16, 2004
Identification of new classes among acute myelogenous leukaemias with normal karyotype using gene expression profilingNorbert Vey, Marie-Joëlle Mozziconacci, Agnès Groulet-Martinec, et al.
Breast Cancer Research and Treatment|June 30, 2010
Gene expression profile predicts outcome after anthracycline-based adjuvant chemotherapy in early breast cancerFrançois Bertucci, Nathalie Borie, Henri Roche, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Cancer Research|December 3, 2004
Gene expression profiling for molecular characterization of inflammatory breast cancer and prediction of response to chemotherapyFrançois Bertucci, Pascal Finetti, Jacques Rougemont, et al.
Experimental Hematology|October 11, 2003
Bone marrow as stem cell source for allogeneic HLA-identical sibling transplantation following reduced-intensity preparative regimenCatherine Faucher, Mohamad Mohty, Norbert Vey, et al.
Experimental Hematology|February 2, 2002
Transient detection of beta-galactosidase activity in hematopoietic cells, following reinjection of retrovirally marked autologous blood progenitors in patients with breast or ovarian cancer receiving high-dose chemotherapyClaude Bagnis, Christian Chabannon, Gwenaelle Gravis, et al.
Blood|April 27, 2011
Individual patient data meta-analysis of randomized trials evaluating IL-2 monotherapy as remission maintenance therapy in acute myeloid leukemiaMarc Buyse, Pierre Squifflet, Beverly J Lange, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 25, 2005
Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study groupMichel Marty, Francesco Cognetti, Dominique Maraninchi, et al.
European Journal of Cancer (Oxford, England : 1990)|December 25, 2004
High-dose chemotherapy with haematopoietic stem cell transplantation for metastatic breast cancer patients: final results of the French multicentric randomised CMA/PEGASE 04 protocolJean-Pierre Lotz, Hervé Curé, Maud Janvier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 28, 2005
Early allogeneic stem-cell transplantation for young adults with acute myeloblastic leukemia in first complete remission: an intent-to-treat long-term analysis of the BGMT experienceEric Jourdan, Jean-Michel Boiron, Nicole Dastugue, et al.
Blood|August 30, 2003
Reduced-intensity preparative regimen and allogeneic stem cell transplantation for advanced solid tumorsDidier Blaise, Jacques Olivier Bay, Catherine Faucher, et al.
Oncogene|November 16, 2004
Identification of new classes among acute myelogenous leukaemias with normal karyotype using gene expression profilingNorbert Vey, Marie-Joëlle Mozziconacci, Agnès Groulet-Martinec, et al.
Breast Cancer Research and Treatment|June 30, 2010
Gene expression profile predicts outcome after anthracycline-based adjuvant chemotherapy in early breast cancerFrançois Bertucci, Nathalie Borie, Henri Roche, et al.
Pageof 5